S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

BDTX Black Diamond Therapeutics Inc

4.70

0.04 (0.86%)

After Hours

Last Updated: 06:30:00

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Black Diamond Therapeutics (NASDAQ:BDTX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Black Diamond Therapeutics Charts.

Black Diamond Therapeutics (NASDAQ:BDTX)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Black Diamond Therapeutics Charts.

Black Diamond Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 7 June 2024 (4 weeks ago) • Edgar (US Regulatory)

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Sunday 2 June 2024 (1 month ago) • GlobeNewswire Inc.

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
Wednesday 29 May 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Tuesday 14 May 2024 (2 months ago) • Edgar (US Regulatory)

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Thursday 9 May 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Thursday 25 April 2024 (2 months ago) • GlobeNewswire Inc.

Black Diamond Therapeutics Announces Changes to Board of Directors
Thursday 11 April 2024 (3 months ago) • GlobeNewswire Inc.

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Monday 8 April 2024 (3 months ago) • GlobeNewswire Inc.

More Black Diamond Therapeutics Inc News Articles

Gold vs US Dollar

Australian SE All Ordina...

National Australia Bank

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions